ACT Capital Management
Latest statistics and disclosures from Act Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are KRYS, CVX, XOM, CELC, TGTX, and represent 48.53% of Act Capital Management's stock portfolio.
- Added to shares of these 10 stocks: ALMS, CELC, FCX, AAOI, XENE, AMZN, NKTR, ABVX, S, PRAX.
- Started 20 new stock positions in Arko Pete Corp, RYZ, AAOI, GLUE, MBX, CRCL, LTRX, ALMS, MU, XENE. HIMS, CMPS, VIR, INCY, S, ONDS, NVDA, VPG, LITE, FCX.
- Reduced shares in these 10 stocks: Celcuity Inc Com Mar 20 26 $50 Call, GPCR, FIGR, SPOT, XOM, NUVB, IBM, Celcuity Inc Com Mar 20 26 $35 Call, BE, EOG.
- Sold out of its positions in ALDX, APGE, BW, DAWN, DVN, EOG, NVNO, FIGR, BTC, IBM. LQDA, MLTX, SNDK, Celcuity Inc Com Mar 20 26 $35 Call, Celcuity Inc Com Mar 20 26 $50 Call, GPCR, TEVA, TVTX, WY, YALA, BHVN, SPOT.
- Act Capital Management was a net seller of stock by $-1.9M.
- Act Capital Management has $127M in assets under management (AUM), dropping by 2.88%.
- Central Index Key (CIK): 0001442273
Tip: Access up to 7 years of quarterly data
Positions held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Act Capital Management
Act Capital Management holds 56 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Krystal Biotech (KRYS) | 12.3 | $16M | 61k | 258.32 |
|
|
| Chevron Corporation (CVX) | 12.2 | $16M | -4% | 75k | 206.90 |
|
| Exxon Mobil Corporation (XOM) | 9.3 | $12M | -15% | 70k | 169.66 |
|
| Celcuity (CELC) | 8.2 | $11M | +44% | 92k | 114.14 |
|
| Tg Therapeutics (TGTX) | 6.5 | $8.3M | -7% | 249k | 33.22 |
|
| Abivax Sa Sponsored Ads (ABVX) | 6.2 | $7.9M | +10% | 71k | 111.35 |
|
| Amazon (AMZN) | 5.4 | $6.9M | +34% | 33k | 208.27 |
|
| Viking Therapeutics (VKTX) | 5.4 | $6.8M | 209k | 32.54 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 4.1 | $5.2M | +10% | 83k | 62.70 |
|
| Nektar Therapeutics Com New (NKTR) | 4.0 | $5.1M | +38% | 71k | 71.95 |
|
| Cytokinetics (CYTK) | 3.3 | $4.3M | 65k | 65.91 |
|
|
| Alumis (ALMS) | 3.0 | $3.8M | NEW | 174k | 22.03 |
|
| Energy Transfer Com Ut Ltd Ptn (ET) | 2.0 | $2.6M | 133k | 19.30 |
|
|
| Freeport-McMoRan Copper & Gold (FCX) | 1.8 | $2.3M | NEW | 39k | 58.78 |
|
| Applied Optoelectronics (AAOI) | 1.7 | $2.2M | NEW | 26k | 84.59 |
|
| Xenon Pharmaceuticals (XENE) | 1.5 | $1.9M | NEW | 34k | 58.15 |
|
| Nuvation Bio Com Cl A (NUVB) | 1.0 | $1.2M | -52% | 290k | 4.29 |
|
| Staar Surgical Com Par $0.01 (STAA) | 0.8 | $1.0M | 56k | 18.70 |
|
|
| Praxis Precision Medicines Com New (PRAX) | 0.7 | $870k | +285% | 2.7k | 322.19 |
|
| Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC) | 0.6 | $813k | -55% | 15k | 52.76 |
|
| Sentinelone Cl A (S) | 0.5 | $699k | NEW | 54k | 12.88 |
|
| Lumentum Hldgs (LITE) | 0.5 | $633k | NEW | 900.00 | 702.76 |
|
| Bloom Energy Corp Com Cl A (BE) | 0.5 | $610k | -65% | 4.5k | 135.49 |
|
| Crescent Energy Company Cl A Com (CRGY) | 0.5 | $608k | -26% | 45k | 13.50 |
|
| Kura Oncology (KURA) | 0.5 | $601k | 74k | 8.13 |
|
|
| Vir Biotechnology (VIR) | 0.5 | $576k | NEW | 64k | 8.96 |
|
| Circle Internet Group Com Cl A (CRCL) | 0.4 | $573k | NEW | 6.0k | 95.41 |
|
| Warrior Met Coal (HCC) | 0.4 | $559k | -50% | 6.0k | 93.15 |
|
| Uipath Cl A (PATH) | 0.4 | $555k | +6% | 50k | 11.10 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.4 | $531k | -10% | 11k | 49.16 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.4 | $514k | +166% | 8.0k | 64.22 |
|
| Micron Technology (MU) | 0.4 | $507k | NEW | 1.5k | 337.84 |
|
| NVIDIA Corporation (NVDA) | 0.4 | $488k | NEW | 2.8k | 174.40 |
|
| Replimune Group (REPL) | 0.4 | $471k | 62k | 7.65 |
|
|
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $469k | -32% | 56k | 8.38 |
|
| Palisade Bio (PALI) | 0.4 | $451k | +71% | 258k | 1.75 |
|
| Olema Pharmaceuticals (OLMA) | 0.3 | $373k | -53% | 25k | 14.91 |
|
| Monte Rosa Therapeutics (GLUE) | 0.3 | $370k | NEW | 23k | 16.45 |
|
| Ondas Com New (ONDS) | 0.3 | $339k | NEW | 38k | 9.04 |
|
| Alpha Cognition (ACOG) | 0.2 | $283k | 52k | 5.49 |
|
|
| Mbx Biosciences (MBX) | 0.2 | $269k | NEW | 9.0k | 29.85 |
|
| Arko Pete Corp Cl A Com | 0.2 | $268k | NEW | 15k | 17.89 |
|
| Kyverna Therapeutics (KYTX) | 0.2 | $259k | +19% | 30k | 8.63 |
|
| Ryerson Tull (RYZ) | 0.2 | $243k | NEW | 11k | 22.48 |
|
| Terra Innovatum Global Nv Ord Shs (NKLR) | 0.2 | $209k | 45k | 4.64 |
|
|
| Incyte Corporation (INCY) | 0.1 | $188k | NEW | 2.0k | 94.12 |
|
| Capricor Therapeutics Com New (CAPR) | 0.1 | $152k | +233% | 5.0k | 30.40 |
|
| Vishay Precision (VPG) | 0.1 | $130k | NEW | 3.0k | 43.42 |
|
| Esperion Therapeutics (ESPR) | 0.1 | $130k | 48k | 2.74 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $125k | 9.0k | 13.90 |
|
|
| Lightspeed Commerce Sub Vtg Shs (LSPD) | 0.1 | $112k | 13k | 8.96 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $86k | NEW | 16k | 5.53 |
|
| Lantronix (LTRX) | 0.1 | $79k | NEW | 15k | 5.24 |
|
| Stratasys (SSYS) | 0.1 | $78k | 10k | 7.81 |
|
|
| Hims &hers Health Com Cl A (HIMS) | 0.0 | $52k | NEW | 2.5k | 20.76 |
|
| Pds Biotechnology Ord (PDSB) | 0.0 | $18k | 30k | 0.60 |
|
Past Filings by Act Capital Management
SEC 13F filings are viewable for Act Capital Management going back to 2021
- Act Capital Management 2026 Q1 filed May 8, 2026
- Act Capital Management 2025 Q4 filed Feb. 17, 2026
- Act Capital Management 2022 Q3 filed Nov. 3, 2022
- Act Capital Management 2022 Q2 filed Aug. 12, 2022
- Act Capital Management 2022 Q1 filed May 11, 2022
- Act Capital Management 2021 Q4 filed Feb. 3, 2022
- ACT Capital 2021 Q3 filed Nov. 16, 2021
- ACT Capital Management 2021 Q2 filed Aug. 16, 2021